Exploring the Adoption of Implantable Brain Stimulation into Standard of Care for Central Nervous System Disorders Proceedings of a Workshop (2024) / Chapter Skim
Currently Skimming:
Appendix B: Workshop Agenda
Appendix B: Workshop Agenda
Pages 73-78
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 73... ...
Appendix B Workshop Agenda EXPLORING THE ADOPTION OF IMPLANTABLE BRAIN STIMULATION INTO STANDARD OF CARE FOR CENTRAL NERVOUS SYSTEM DISORDERS The Keck Center, 500 Fifth Street, NW Washington, DC 20001 OCTOBER 31, 2023 ROOM 100 9:00–9:05 Welcome Frances Jensen, University of Pennsylvania; Co-chair, Forum on Neuroscience and Nervous System Disorders John Krystal, Yale University; Co-chair, Forum on Neurosci ence and Nervous System Disorders SESSION 1 -- CROSSING THE CHASM: LESSONS LEARNED ACROSS TECHNOLOGIES • R eview the current state of knowledge regarding the clinical utilization of implantable brain stimulation across various CNS disorders and con sider the future potential to improve quality of life for patients. • Discuss the lessons learned from other technologies that have or have not "crossed the chasm" to be adopted into clinical care.
|
From page 74... ...
Overview of Approved Neuromodulation Therapies Vivek Pinto, U.S. Food and Drug Administration Cochlear Implants and Retinal Implants Carla Mann Woods, Adventus Ventures Responsive Neurostimulation for Epilepsy Mindy Ganguly, University of Pennsylvania Deep Brain Stimulation for Obsessive-Compulsive Disorder (OCD)
|
From page 75... ...
• Consider what challenges and barriers prevent patients from selecting this treatment or causes patients to perceive the treatment as a failure. 10:00–10:05 Session Overview Laura Lubbers, CURE Epilepsy 10:05–10:25 Speaker Remarks Steve Austin, CURE Epilepsy Jim McNasby, Michael J
|
From page 76... ...
12:55–1:00 Session Overview David McMullen, Food and Drug Administration 1:00–2:00 Moderated Panel and Audience Q&A Lauren Hammer, University of California, San Francisco (Zoom) Joan Miravite, Icahn School of Medicine at Mount Sinai Martha Morrell, NeuroPace, Inc.
|
From page 77... ...
3:25–3:30 Session Overview Tim Denison, University of Oxford; Workshop Co-chair Helen Mayberg, Icahn School of Medicine at Mount Sinai; Workshop Co-chair 3:30–4:25 Moderated Panel and Audience Q&A Brandy Ellis, Neuromodulation Patient Advocate Lauren Hammer, University of California, San Francisco (Zoom) Doug Kelly, Food and Drug Administration Sarah Hollingsworth Lisanby, National Institute of Mental Health Kevin Mahoney, University of Pennsylvania Health System Chris Pulliam, Case Western University PREPUBLICATION COPY -- Uncorrected Proofs
|
From page 78... ...
78 EXPLORING THE ADOPTION OF IMPLANTABLE BRAIN STIMULATION 4:25–4:30 Synthesis and Concluding Remarks Tim Denison, University of Oxford; Workshop Co-chair Helen Mayberg, Icahn School of Medicine at Mount Sinai; Workshop Co-chair PREPUBLICATION COPY -- Uncorrected Proofs
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.